| scholarly article | Q13442814 |
| P2093 | author name string | A R Tall | |
| L Martin | |||
| C J Mann | |||
| R W Milne | |||
| Y L Marcel | |||
| R McPherson | |||
| M Hogue | |||
| P433 | issue | 4 | |
| P921 | main subject | lipoprotein | Q28350 |
| P304 | page(s) | 797-804 | |
| P577 | publication date | 1991-07-01 | |
| P1433 | published in | Arteriosclerosis and thrombosis : a journal of vascular biology | Q27709770 |
| P1476 | title | Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia. Relation to cholesteryl ester transfer protein activity and other lipoprotein variables | |
| P478 | volume | 11 |
| Q90068241 | ApoF knockdown increases cholesteryl ester transfer to LDL and impairs cholesterol clearance in fat-fed hamsters |
| Q51312722 | Association between ABCG1 polymorphism rs1893590 and high-density lipoprotein (HDL) in an asymptomatic Brazilian population. |
| Q33639433 | Association of circulating cholesteryl ester transfer protein activity with incidence of cardiovascular disease in the community |
| Q26753158 | CETP Inhibition: Past Failures and Future Hopes |
| Q42103732 | CETP Lowers TLR4 Expression Which Attenuates the Inflammatory Response Induced by LPS and Polymicrobial Sepsis |
| Q71873585 | Cholesteryl ester transfer protein inhibition in hypercholesterolemic hamsters: Kinetics of apoprotein changes |
| Q37444625 | Ciprofibrate increases cholesteryl ester transfer protein gene expression and the indirect reverse cholesterol transport to the liver |
| Q37150845 | Circulating PCSK9 levels and CETP plasma activity are independently associated in patients with metabolic diseases |
| Q42931710 | Design, Synthesis, and Biological Evaluation of Benzylamino-Methanone Based Cholesteryl Ester Transfer Protein Inhibitors |
| Q34705747 | Function of cholesteryl ester transfer protein in reverse cholesterol transport |
| Q35839693 | Impact of LDL apheresis on atheroprotective reverse cholesterol transport pathway in familial hypercholesterolemia |
| Q80268629 | Influence of dyslipidemia on moxidectin distribution in plasma lipoproteins and on its pharmacokinetics |
| Q34216211 | Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia |
| Q37130807 | Molecular cloning of hamster lipid transfer inhibitor protein (apolipoprotein F) and regulation of its expression by hyperlipidemia |
| Q34441411 | Monogenic causes of elevated HDL cholesterol and implications for development of new therapeutics. |
| Q42811198 | Plasma activities of lecithin:cholesterol acyltransferase, lipid transfer proteins and post-heparin lipases in inbred strains of rabbits hypo- or hyper-responsive to dietary cholesterol |
| Q43695445 | Plasma cholesteryl ester transfer protein and lipoprotein levels during treatment of growth hormone-deficient adult humans. |
| Q27021950 | The roles of genetic polymorphisms and human immunodeficiency virus infection in lipid metabolism |
| Q45838620 | Use of bile correction factors for allometric prediction of human pharmacokinetic parameters of torcetrapib, a facile cholesteryl ester transfer protein inhibitor |
Search more.